Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

46.48

-0.27 (-0.58%)

At close: Aug 26, 2026, 4:00 PM EDT

46.20

-0.28 (-0.60%)

After-hours: Aug 26, 2026, 7:30 PM EDT

Rigel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	868	777	296	253	259	453
Market Cap Growth	18.81%	162.39%	17.18%	-2.48%	-42.79%	-23.38%
Enterprise Value	813	701	335	295	269	403
Last Close Price	46.48	42.83	16.82	14.50	15.00	26.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	2.83	2.12	16.95	-	-	-
Forward PE	14.49	10.49	17.39	-	-	-
PS Ratio	3.14	2.64	1.65	2.16	2.24	3.27
PB Ratio	2.04	1.99	90.11	-8.83	-19.04	14.92
P/TBV Ratio	2.62	2.12	-	-	-	14.92
P/FCF Ratio	10.94	10.28	9.43	-	-	86.30
P/OCF Ratio	10.94	10.28	9.41	-	-	77.10

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.94	2.38	1.87	2.52	2.33	2.90
EV/EBITDA Ratio	9.06	5.48	12.69	-	-	-
EV/EBIT Ratio	9.34	5.59	13.86	-	-	-
EV/FCF Ratio	10.24	9.27	10.67	-	-	76.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.09	0.14	30.40	-3.64	-6.44	3.01
Debt / EBITDA Ratio	0.44	0.41	3.68	-	-	-
Debt / FCF Ratio	0.50	0.71	3.18	-	-	17.38
Net Debt / Equity Ratio	-0.13	-0.26	6.88	-1.65	-2.17	-1.11
Net Debt / EBITDA Ratio	-0.62	-0.79	0.86	-2.45	-0.51	1.84
Net Debt / FCF Ratio	-0.70	-1.34	0.72	-8.22	-0.40	-6.42
Asset Turnover	0.76	0.87	1.27	0.93	0.77	1.00
Inventory Turnover	3.38	3.20	5.50	2.76	5.17	10.82
Quick Ratio	1.58	2.08	1.88	1.64	1.51	2.21
Current Ratio	1.94	2.42	2.13	1.86	1.78	2.43
Return on Equity (ROE)	126.90%	185.94%	-	-	-699.04%	-55.63%
Return on Assets (ROA)	14.95%	23.15%	10.75%	-10.18%	-24.34%	-8.77%
Return on Invested Capital (ROIC)	26.02%	79.47%	51.25%	-30.81%	-178.67%	-312.65%
Return on Capital Employed (ROCE)	20.50%	30.30%	24.00%	-32.00%	-85.00%	-18.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	37.08%	47.21%	5.90%	-9.92%	-22.59%	-3.95%
FCF Yield	9.14%	9.73%	10.61%	-2.27%	-28.62%	1.16%
Buyback Yield / Dilution	-8.67%	-6.52%	-1.64%	-2.07%	0.00%	-1.03%

SEC Filings: 10-K · 10-Q